MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202441047693 A) filed by Sciinv Biosciences Pvt. Ltd., Hyderabd, Telangana, on Dec. 21, 2024, for 'generative ai based antimicrobial resistance drug discovery platform.'
Inventor(s) include Uday Saxena; Pallu Reddanna; Ranga Reddy Burri; Bulagonda Eswarappa Pradeep; Palakodeti Ratnakar; Ravi Kumar Meduri; and Ratna Sushmita Mandavalli.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a field of using generative artificial intelligence for drug repurposing. The current invention uses artificial intelligence enabled p...